FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD: CLINICAL AND SIDE EFFECTS
Saved in:
AMAN, M.G., ET AL., FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD: CLINICAL AND SIDE EFFECTS. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 32, no. 4 (1993), p. 851-859.
Ref.
38124
Location:
SIIS SIIS Madrid R.598
Palabras clave:
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Tratamiento
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Tratamiento
Similar Items: FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD: CLINICAL AND SIDE EFFECTS
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND BORDELINE IQ: CLINICAL EFFECTS
- ADVERSE SIDE EFFECTS OF METHYLPHENIDATE AMONG MENTALLY RETARDED CHILDREN WITH ADHD
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ATTENTION DEFICIT HYPERACTIVITY DISORDER: LABORATORY EFFECTS
- PREDICTION OF RESPONSE TO METHYLPHENIDATE AMONG CHILDREN WITH ADHD AND MENTAL RETARDATION
- PREDICTION OF RESPONSE TO METHYLPHENIDATE AMONG CHILDREN WITH ADHD AND MENTAL RETARDATION
- EFFECTS AND NONEFFECTS OF METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD